The Community Guide

- gsearch

Search Results

Narrow Results:

2021 3
2018 2
2017 2
2014 1
2012 1
2011 1

Journal Article 10

1 - 10 of 10 Results

Refine Results

Refine Results:

Pooled PCR testing strategy and prevalence estimation of submicroscopic infections using Bayesian latent class models in pregnant women receiving intermittent preventive treatment at Machinga District Hospital, Malawi, 2010

CITE Title : Pooled PCR testing strategy and prevalence estimation of submicroscopic infections using Bayesian latent class models in pregnant women receiving intermittent preventive treatment at Machinga District Hospital, Malawi, 2010 Personal Author(s) : Zhou, Zhiyong;Mitchell, Rebecca Mans;Gutman, Julie;Wiegand, Ryan E;Mwandama, Dyson A;Mathanga, Don P;Skarbinski, Jacek;Shi, Ya Ping; Published Date : Dec 18 2014 Source : Malar J. 13. URL : https://stacks.cdc.gov/view/cdc/27140 Zhou, Zhiyong et al. (2014). Pooled PCR testing strategy and prevalence estimation of submicroscopic infections using Bayesian latent class models in pregnant women receiving intermittent preventive treatment at Machinga District Hospital, Malawi, 2010. 13 Zhou, Zhiyong et al. "Pooled PCR testing strategy and prevalence estimation of submicroscopic infections using Bayesian latent class models in pregnant women receiving intermittent preventive treatment at Machinga District Hospital, Malawi, 2010" 13 (2014) Zhou, Zhiyong et al. "Pooled PCR testing strategy and prevalence estimation of submicroscopic infections using Bayesian latent class models in pregnant women receiving intermittent preventive treatment at Machinga District Hospital, Malawi, 2010" vol. 13, 2014 Export RIS Citation Information.

:

Zhou, Zhiyong ;

Mitchell, Rebecca Mans

Dec 18 2014 | Malar J. 13.

:

BackgroundLow malaria parasite densities in pregnancy are a diagnostic challenge. PCR provides high sensitivity and specificity in detecting low densi...
Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ethiopia: absence of common African and Mediterranean allelic variants in a nationwide study

CITE Title : Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ethiopia: absence of common African and Mediterranean allelic variants in a nationwide study Personal Author(s) : Assefa, Ashenafi;Ali, Ahmed;Deressa, Wakgari;Tsegaye, Wendimagegn;Abebe, Getachew;Sime, Heven;Kebede, Amha;Jima, Daddi;Kassa, Moges;Abreha, Tesfay;Teka, Hiwot;Solomon, Hiwot;Malone, Joseph;Shi, Ya Ping;Zhou, Zhiyong;Reithinger, Richard;Hwang, Jimee; Published Date : Oct 26 2018 Source : Malar J. 17. URL : https://stacks.cdc.gov/view/cdc/60914 Assefa, Ashenafi et al. (2018). Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ethiopia: absence of common African and Mediterranean allelic variants in a nationwide study. 17 Assefa, Ashenafi et al. "Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ethiopia: absence of common African and Mediterranean allelic variants in a nationwide study" 17 (2018) Assefa, Ashenafi et al. "Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ethiopia: absence of common African and Mediterranean allelic variants in a nationwide study" vol. 17, 2018 Export RIS Citation Information.

:

Assefa, Ashenafi ;

Ali, Ahmed

Oct 26 2018 | Malar J. 17.

:

BackgroundBuilding on the declining trend of malaria in Ethiopia, the Federal Ministry of Health aims to eliminate malaria by 2030. As Plasmodium falc...
Detection of minority drug resistant mutations in Malawian HIV-1 subtype C-positive patients initiating and on first-line antiretroviral therapy

CITE Title : Detection of minority drug resistant mutations in Malawian HIV-1 subtype C-positive patients initiating and on first-line antiretroviral therapy Personal Author(s) : Zhou, Zhiyong;Tang, Kevin;Zhang, Guoqing;Wadonda-Kabondo, Nellie;Moyo, Kundai;Rowe, Lori A.;DeVos, Joshua R.;Wagar, Nick;Zheng, Du-Ping;Guo, Hongxiong;Nkengasong, John;Frace, Mike;Sammons, Scott;Yang, Chunfu; Published Date : May 30 2018 Source : Afr J Lab Med. 2018; 7(1). URL : https://stacks.cdc.gov/view/cdc/58828 Zhou, Zhiyong et al. (2018). Detection of minority drug resistant mutations in Malawian HIV-1 subtype C-positive patients initiating and on first-line antiretroviral therapy. 7(1). Zhou, Zhiyong et al. "Detection of minority drug resistant mutations in Malawian HIV-1 subtype C-positive patients initiating and on first-line antiretroviral therapy" 7, no. 1 (2018) Zhou, Zhiyong et al. "Detection of minority drug resistant mutations in Malawian HIV-1 subtype C-positive patients initiating and on first-line antiretroviral therapy" vol. 7, no. 1, 2018 Export RIS Citation Information.

:

Zhou, Zhiyong ;

Tang, Kevin

May 30 2018 | Afr J Lab Med. 2018; 7(1).

:

BackgroundMinority drug resistance mutations (DRMs) that are often missed by Sanger sequencing are clinically significant, as they can cause virologic...
Plasmodium falciparum kelch13 Mutations, 9 Countries in Africa, 2014–2018

CITE Title : Plasmodium falciparum kelch13 Mutations, 9 Countries in Africa, 2014–2018 Personal Author(s) : Schmedes, Sarah E.;Patel, Dhruviben;Dhal, Simran;Kelley, Julia;Svigel, Samaly S.;Dimbu, Pedro Rafael;Adeothy, Adicatou-Laï;Kahunu, Gauthier Mesia;Nkoli, Papy Mandoko;Beavogui, Abdoul Habib;Kariuki, Simon;Mathanga, Don P.;Koita, Ousmane;Ishengoma, Deus;Mohamad, Ally;Hawela, Moonga;Moriarty, Leah F.;Samuels, Aaron M.;Gutman, Julie;Plucinski, Mateusz M.;Udhayakumar, Venkatachalam;Zhou, Zhiyong;Lucchi, Naomi W.;Venkatesan, Meera;Halsey, Eric S.;Talundzic, Eldin; Published Date : July 2021 Source : Emerg Infect Dis. 27(7):1902-1908 URL : https://stacks.cdc.gov/view/cdc/107950 Schmedes, Sarah E. et al. (2021). Plasmodium falciparum kelch13 Mutations, 9 Countries in Africa, 2014–2018. 27(7). Schmedes, Sarah E. et al. "Plasmodium falciparum kelch13 Mutations, 9 Countries in Africa, 2014–2018" 27, no. 7 (2021) Schmedes, Sarah E. et al. "Plasmodium falciparum kelch13 Mutations, 9 Countries in Africa, 2014–2018" vol. 27, no. 7, 2021 Export RIS Citation Information.

:

Schmedes, Sarah E. ;

Patel, Dhruviben

July 2021 | Emerg Infect Dis. 27(7):1902-1908

:

The spread of drug resistance to antimalarial treatments poses a serious public health risk globally. To combat this risk, molecular surveillance of d...
Capacity Development through the US President’s Malaria Initiative–Supported Antimalarial Resistance Monitoring in Africa Network

CITE Title : Capacity Development through the US President’s Malaria Initiative–Supported Antimalarial Resistance Monitoring in Africa Network Personal Author(s) : Halsey, Eric S.;Venkatesan, Meera;Plucinski, Mateusz M.;Talundzic, Eldin;Lucchi, Naomi W.;Zhou, Zhiyong;Mandara, Celine I.;Moonga, Hawela;Hamainza, Busiku;Beavogui, Abdoul Habib;Kariuki, Simon;Samuels, Aaron M.;Steinhardt, Laura C.;Mathanga, Don P.;Gutman, Julie;Denon, Yves Eric;Uwimana, Aline;Assefa, Ashenafi;Hwang, Jimee;Shi, Ya Ping;Dimbu, Pedro Rafael;Koita, Ousmane;Ishengoma, Deus S.;Ndiaye, Daouda;Udhayakumar, Venkatachalam; Published Date : Dec 2017 Source : Emerg Infect Dis. 23(Suppl 1):S53-S56. URL : https://stacks.cdc.gov/view/cdc/50081 Halsey, Eric S. et al. (2017). Capacity Development through the US President’s Malaria Initiative–Supported Antimalarial Resistance Monitoring in Africa Network. 23 Halsey, Eric S. et al. "Capacity Development through the US President’s Malaria Initiative–Supported Antimalarial Resistance Monitoring in Africa Network" 23 (2017) Halsey, Eric S. et al. "Capacity Development through the US President’s Malaria Initiative–Supported Antimalarial Resistance Monitoring in Africa Network" vol. 23, 2017 Export RIS Citation Information.

:

Halsey, Eric S. ;

Venkatesan, Meera

Dec 2017 | Emerg Infect Dis. 23(Suppl 1):S53-S56.

:

Antimalarial drug resistance is an evolving global health security threat to malaria control. Early detection of Plasmodium falciparum resistance thro...
Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial

CITE Title : Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial Personal Author(s) : Abreha, Tesfay;Hwang, Jimee;Thriemer, Kamala;Tadesse, Yehualashet;Girma, Samuel;Melaku, Zenebe;Assef, Ashenafi;Kassa, Moges;Chatfield, Mark D.;Landman, Keren Z.;Chenet, Stella M.;Lucchi, Naomi W.;Udhayakumar, Venkatachalam;Zhou, Zhiyong;Shi, Ya Ping;Kachur, S. Patrick;Jima, Daddi;Kebede, Amha;Solomon, Hiwot;Mekasha, Addis;Alemayehu, Bereket Hailegiorgis;Malone, Joseph L.;Dissanayake, Gunewardena;Teka, Hiwot;Auburn, Sarah;von Seidlein, Lorenz;Price, Ric N.; Published Date : May 16 2017 Source : PLoS Med. 14(5). URL : https://stacks.cdc.gov/view/cdc/60927 Abreha, Tesfay et al. (2017). Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial. 14(5). Abreha, Tesfay et al. "Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial" 14, no. 5 (2017) Abreha, Tesfay et al. "Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial" vol. 14, no. 5, 2017 Export RIS Citation Information.

:

Abreha, Tesfay ;

Hwang, Jimee

May 16 2017 | PLoS Med. 14(5).

:

BackgroundRecent efforts in malaria control have resulted in great gains in reducing the burden of Plasmodium falciparum, but P. vivax has been more r...
Development of a new barcode-based, multiplex-PCR, next-generation-sequencing assay and data processing and analytical pipeline for multiplicity of infection detection of Plasmodium falciparum

CITE Title : Development of a new barcode-based, multiplex-PCR, next-generation-sequencing assay and data processing and analytical pipeline for multiplicity of infection detection of Plasmodium falciparum Personal Author(s) : Mitchell, Rebecca M.;Zhou, Zhiyong;Sheth, Mili;Sergent, Sheila;Frace, Michael;Nayak, Vishal;Hu, Bin;Gimnig, John;ter Kuile, Feiko;Lindblade, Kim;Slutsker, Laurence;Hamel, Mary J.;Desai, Meghna;Otieno, Kephas;Kariuki, Simon;Vigfusson, Ymir;Shi, Ya Ping; Published Date : 2 16 2021 Source : Malar J. 20 URL : https://stacks.cdc.gov/view/cdc/111631 Mitchell, Rebecca M. et al. (2021). Development of a new barcode-based, multiplex-PCR, next-generation-sequencing assay and data processing and analytical pipeline for multiplicity of infection detection of Plasmodium falciparum. 20 Mitchell, Rebecca M. et al. "Development of a new barcode-based, multiplex-PCR, next-generation-sequencing assay and data processing and analytical pipeline for multiplicity of infection detection of Plasmodium falciparum" 20 (2021) Mitchell, Rebecca M. et al. "Development of a new barcode-based, multiplex-PCR, next-generation-sequencing assay and data processing and analytical pipeline for multiplicity of infection detection of Plasmodium falciparum" vol. 20, 2021 Export RIS Citation Information.

:

Mitchell, Rebecca M. ;

Zhou, Zhiyong

2 16 2021 | Malar J. 20

:

BackgroundSimultaneous infection with multiple malaria parasite strains is common in high transmission areas. Quantifying the number of strains per ho...
Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study

CITE Title : Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study Personal Author(s) : Uwimana, Aline;Umulisa, Noella;Venkatesan, Meera;Svigel, Samaly S;Zhou, Zhiyong;Munyaneza, Tharcisse;Habimana, Rafiki M;Rucogoza, Anicet;Moriarty, Leah F;Sandford, Ryan;Piercefield, Emily;Goldman, Ira;Ezema, Bryan;Talundzic, Eldin;Pacheco, M Andreína;Escalante, Ananias A;Ngamije, Daniel;Mangala, Jean-Louis N;Kabera, Michee;Munguti, Kaendi;Murindahabi, Monique;Brieger, William;Musanabaganwa, Clarisse;Mutesa, Leon;Udhayakumar, Venkatachalam;Mbituyumuremyi, Aimable;Halsey, Eric S;Lucchi, Naomi W; Published Date : 8 2021 Source : Lancet Infect Dis. 21(8):1120-1128 URL : https://stacks.cdc.gov/view/cdc/128784 Uwimana, Aline et al. (2021). Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study. 21(8). Uwimana, Aline et al. "Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study" 21, no. 8 (2021) Uwimana, Aline et al. "Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study" vol. 21, no. 8, 2021 Export RIS Citation Information.

:

Uwimana, Aline ;

Umulisa, Noella

8 2021 | Lancet Infect Dis. 21(8):1120-1128

:

BackgroundPartial artemisinin resistance is suspected if delayed parasite clearance (ie, persistence of parasitaemia on day 3 after treatment initiati...
Optimization of a Low Cost and Broadly Sensitive Genotyping Assay for HIV-1 Drug Resistance Surveillance and Monitoring in Resource-Limited Settings

CITE Title : Optimization of a Low Cost and Broadly Sensitive Genotyping Assay for HIV-1 Drug Resistance Surveillance and Monitoring in Resource-Limited Settings Personal Author(s) : Zhou, Zhiyong;Wagar, Nick;DeVos, Joshua R.;Rottinghaus, Erin;Diallo, Karidia;Nguyen, Duc B.;Bassey, Orji;Ugbena, Richard;Wadonda-Kabondo, Nellie;McConnell, Michelle S.;Zulu, Isaac;Chilima, Benson;Nkengasong, John;Yang, Chunfu; Published Date : Nov 23 2011 Source : PLoS One. 2011; 6(11). URL : https://stacks.cdc.gov/view/cdc/4353 Zhou, Zhiyong et al. (2011). Optimization of a Low Cost and Broadly Sensitive Genotyping Assay for HIV-1 Drug Resistance Surveillance and Monitoring in Resource-Limited Settings. 6(11). Zhou, Zhiyong et al. "Optimization of a Low Cost and Broadly Sensitive Genotyping Assay for HIV-1 Drug Resistance Surveillance and Monitoring in Resource-Limited Settings" 6, no. 11 (2011) Zhou, Zhiyong et al. "Optimization of a Low Cost and Broadly Sensitive Genotyping Assay for HIV-1 Drug Resistance Surveillance and Monitoring in Resource-Limited Settings" vol. 6, no. 11, 2011 Export RIS Citation Information.

:

Zhou, Zhiyong ;

Wagar, Nick

Nov 23 2011 | PLoS One. 2011; 6(11).

:

ConclusionsThe optimized in-house assay is broadly sensitive in genotyping HIV-1 group M viral strains and more sensitive than the original in-house, ...
Differences in selective pressure on dhps and dhfr drug resistant mutations in western Kenya

CITE Title : Differences in selective pressure on dhps and dhfr drug resistant mutations in western Kenya Personal Author(s) : McCollum, Andrea M;Schneider, Kristan A;Griffing, Sean M;Zhou, Zhiyong;Kariuki, Simon;Ter-Kuile, Feiko;Shi, Ya Ping;Slutsker, Laurence;Lal, Altaf A;Udhayakumar, Venkatachalam;Escalante, Ananias A; Published Date : Mar 22 2012 Source : Malar J. 2012; 11:77. URL : https://stacks.cdc.gov/view/cdc/8007 McCollum, Andrea M et al. (2012). Differences in selective pressure on dhps and dhfr drug resistant mutations in western Kenya. 11 McCollum, Andrea M et al. "Differences in selective pressure on dhps and dhfr drug resistant mutations in western Kenya" 11 (2012) McCollum, Andrea M et al. "Differences in selective pressure on dhps and dhfr drug resistant mutations in western Kenya" vol. 11, 2012 Export RIS Citation Information.

:

McCollum, Andrea M ;

Schneider, Kristan A

Mar 22 2012 | Malar J. 2012; 11:77.

:

BackgroundUnderstanding the origin and spread of mutations associated with drug resistance, especially in the context of combination therapy, will hel...